1. Published Name of the Standard for which request is being made (if previously published)

HL7 CDA® R2 Implementation Guide: Pharmacy Templates, Edition 1

2. Standards Material/Document

STU

3. Date of Request

Mar 20, 2023

4. Use Period

two years

5. Reason for extension, timeline, and actions

6. Original Publication Date

7. End date of the current STU period

8. Length of the requested extension

9. Review Process

10. HL7 Work Group making this request and date

Pharmacy WG

10a. Requesting WG Date

Mar 20, 2023

11. URL of approval minutes

https://confluence.hl7.org/pages/viewpage.action?pageId=161058405

12. HL7 Product Management Group

CDA MG

12a. Management Group Date of Approval

Apr 05, 2023

13. URL of approval minutes

https://confluence.hl7.org/display/CDA/2023-04-05+CMG+Meeting+Notes

14. Is the artifact ready for final publication?

Yes

15. If not ready, please describe remaining steps.

16. Tool name used to produce the machine processable artifacts in the IG

ART DECOR

17. The name of the “IG artifact” within the context of the above mentioned tool.

Medication on CDA
https://art-decor.org/art-decor/decor-project--pharmcda-

18. Balloted Name of the standard for which request is being made

HL7 CDA® R2 Implementation Guide: Pharmacy Templates, Release 1 STU Release 2

19. Requested name for published standard. See Naming Examples

HL7 CDA® R2 Implementation Guide: Pharmacy Templates, Edition 1 STU Release 2

19a. Specification Feedback Name (For Search in Jira)

20. If CMET, list IDs balloted

21. Project Insight Number

1139

22. Document Realm

UV

23. Ballot cycle in which the document was successfully balloted

2022-Sep

25. Affirmative

33

26. Negative

10

27. Abstentions

37

28. Not Returned

23

29. Total in ballot pool

103

30. Date on which final document/standards material was supplied to HQ

Mar 10, 2023

31. URL of publication material/ SVN repository

https://github.com/HL7/CDA-pharma/blob/main/input/CDAR2_IG_PHARM_TEMPLATES_E1_STU2_2023APR.zip

32. Publishing Facilitator

Giorgio Cangioli

33. Special Publication Instructions

34. URL of ballot reconciliation document

http://www.hl7.org/documentcenter/public/ballots/2022SEP/reconciliation/recon_cdar2_ig_pharm_templates_r1_d3_2022sep.xls

35. Has the Work Group posted its consideration of all comments received in its reconciliation document on the ballot desktop?

Yes

36. Substantive Changes Since Last Ballot?

No

37. Product Brief Reviewed By

Pharmacy WG

38. Date Product Brief Reviewed

Mar 20, 2023

39. Has the Product Brief changed?

40. Family

CDA

41. Section

Implementation Guides

42. Topic

Pharmacy

43. Please Describe the Topic

44. Product Type

Implementation Guide

45. Parent standard

HL7 CDA R2

46. Parent Standard Status

Move to Stable

47. Update/replace standard

48. Common name/search keyword

"HL7 CDA® R2 IG: Pharmacy Templates, R1",
Pharmacy Templates
Templates
Pharmacy CDA Templates
Pharmacy Universal Templates

49. Description

This Implementation Guide provides CDA R2 templates for Medication Order and Medication Statement, Medication Dispense and Medication Administration that can be used by HL7 standards developers and external projects to develop models for pharmacy related content. The implementation guide is intended to provide consistency of pharmacy related models across all uses regardless of the method of transport by creating a library of Universal (UV) Pharmacy Templates that can be used by other Work Groups to derive constrained versions.

50. Stakeholders

Clinical and Public Health Laboratories, Standards Development Organizations (SDOs), Payors

51. Vendors

Pharmaceutical, EHR, PHR, Health Care IT

52. Providers

Healthcare Institutions (hospitals, long term care, home care, mental health)

53. Benefits

Enables HL7 standards developers and external projects to develop models for pharmacy related content.
Provides consistency of pharmacy related models across all uses regardless of the method of transport by creating a library of Universal (UV) Pharmacy Templates that can be used by other Work Groups to derive constrained versions

54. Implementations/Case Studies

HL7 International – International Patient Summary (IPS)
European Cross Border Services (MyHealth@EU)

55. Development Background

Historically multiple HL7 Work Groups have developed specifications for pharmacy related content and as a result, there is inconsistency in how medication related content is represented in HL7 V2, V3, CDA and FHIR. The Pharmacy Work Group often receives questions as to how to model pharmacy related content but in some cases, the use case cannot be met with the existing models.

This Implementation Guide provides a CDA R2 library of pharmacy templates that can be used by HL7 Work Groups or external projects to derive constrained versions of models for pharmacy related content.







1 Comment

  1. Tallies in 25-29 subject to a temporary error March 8, 2023 until the fix was implemented on May 1st in calculations on the ballot tally page, but actually ballot desktop reads 41/10/40/24/115